a milestone in the rise of domestic production

March 12, 2025  Source: drugdu 37

"/In January 2025, the Guizhou Provincial Health Commission launched a centralized procurement project for CT equipment. The total budget of the project is as high as 175.25 million yuan, covering the procurement of 13 sets of CT equipment. Recently, it was announced that the total bid amount for this centralized procurement project was only 78.03 million yuan, which is 44.5% of the budget. Domestic brand CT equipment performed well, and Neusoft Medical became the biggest winner in this bidding, winning 7 sets.

01. Domestic brand wins bid as mainstream
The recently announced winning bid for the CT equipment centralized procurement project by the Guizhou Provincial Health Commission shows that the total bid amount for this centralized procurement project is only 78.03 million yuan, which is only 44.5% of the budget and directly saves nearly 100 million yuan in funds. In fierce competition, domestic CT equipment brands have performed well, with Neusoft Medical, Xinhua Medical, and Anke monopolizing 7 sections and a total of 11 sets of CT equipment. In contrast, foreign brand GE Healthcare only won one bid for a total of two sets of CT equipment.

NeuViz series CT equipment from NeuViz Medical became the biggest winner in this bidding, winning 5 bids and winning 7 sets of CT equipment with a total bid amount of 50.94 million yuan.

02. The Rise of Domestic Brands
The results of this centralized procurement show that the competitiveness of domestic brands in the CT equipment market has significantly improved. The main reasons for the rise of domestic brands are as follows:

 Technological advancement and market recognition
The performance of domestic brands in this centralized procurement is not only a victory in market share, but also a reflection of their technological strength. In recent years, the technological breakthroughs of domestic brands in the field of CT equipment are evident to all. For example, in this procurement, sections 2, 6, and 8 all accept imported products. But according to the announcement of the winning bid results, XHCT-16 from Xinhua Medical won the bid for Section 2; NeuViz Epoch equipment from Neusoft Medical has won bids for sections 6 and 8, demonstrating its competitiveness in the high-end CT market by winning bids in multiple sections.

From a technical perspective, domestic brands have already dominated the 64 row and below CT market, with a localization rate exceeding 56% by 2024. In the high-end CT market above 64 rows, the localization rate has rapidly increased to 47%, indicating the rapid rise of domestic brands in the high-end technology field.

 Policy support and market opportunities
The rise of domestic brands cannot be separated from policy support. In recent years, the country has attached increasing importance to the localization of medical equipment and has introduced a series of policies to encourage medical institutions to purchase domestically produced equipment. For example, in May 2024, the National Development and Reform Commission and four other departments issued the "Notice on Promoting the Implementation Plan for Updating Medical and Health Equipment", which clearly stated the support for county-level and grassroots medical institutions to equip CT and other medical equipment. This policy not only promotes the market penetration of CT equipment, but also provides broad development space for domestic brands.

In this centralized procurement by the Guizhou Health Commission, multiple sections explicitly did not accept imported products, providing opportunities for domestic brands. In this procurement, 5 out of 8 sections do not accept imported products. Brands such as Neusoft Medical, Xinhua Medical, and Anke have successfully won multiple bids with their technological strength and cost-effectiveness advantages, further consolidating their position in the market. Especially NeuViz series CT equipment from Neusoft Medical accounted for 65.3% of the total bid amount, demonstrating a high advantage.

 Cost control and cost-effectiveness advantages
The advantages of domestic brands in cost control and cost-effectiveness are one of the key factors contributing to their rise. In this centralized procurement, the winning bid prices of domestic brands were generally lower than the budgeted prices, demonstrating their strong ability in cost control. Anke, Xinhua Medical, and Neusoft Medical Equipment won the bid at prices lower than the budget in multiple sections, which not only saved the purchasing party a lot of money, but also won market share for themselves.

From the perspective of market trends, domestic brands have taken a dominant position in the mid to low end market and are gradually penetrating into the high-end market. In the first three quarters of 2024, the localization rate of the domestic CT market further increased to 52.61%, an increase of 4 percentage points compared to the same period last year. This trend indicates that domestic brands are not only competitive in price, but also gradually narrowing the gap with foreign brands in technology.

03. Changes in Market Landscape and Future Trends: Reshaping the Market Landscape
The CT centralized procurement project of Guizhou Health Commission is a microcosm of the rise of domestic brands. In recent years, the landscape of the domestic CT market has undergone profound changes. The market share of CT national brands in China continues to grow, exceeding 53% in 2024, an increase of 18.4 percentage points compared to 2020.

In the first three quarters of 2024, among the top five CT brands in the domestic market, the market share of domestic brand Lianying Medical has significantly increased, while foreign brands such as GE Healthcare and Siemens Healthineers still occupy important positions, but their market share growth is slow.

In the county-level hospital market, GE Healthcare and Lianying Medical have increased their market share, but domestic brands such as Neusoft Medical and Anke are gradually expanding their influence. In the future, with the further improvement of domestic brand technology and the further opening up of the market, the pattern of the domestic CT market is expected to be further reshaped.

Future Trends and Prospects
The rise of domestic brands is not only the result of technological breakthroughs, but also the inevitable result of market demand and policy guidance. In the future, as the country's emphasis on primary healthcare continues to increase, the downward trend of the CT equipment market will become more apparent. Domestic brands, with their cost-effectiveness and technological strength, will play an important role in this process.

From the perspective of technological development trends, the localization rate of domestic brands in the high-end CT market will continue to increase. In 2024, the localization rate of the high-end CT market above 64 rows is growing rapidly, demonstrating the breakthrough of domestic brands in the field of high-end technology. In the future, with the further development of technology, domestic brands are expected to achieve breakthroughs in more high-end fields and gradually break the monopoly of foreign brands.

From the perspective of market regions, there has been a significant increase in CT procurement demand in the eastern and western regions, while there has been a decrease in demand in the central region. This trend indicates that the performance of domestic brands in regional markets will become more diversified. In the future, domestic brands need to develop differentiated market strategies based on the characteristics of regional markets to further expand their market share.

The CT centralized procurement project of Guizhou Health Commission is not only an important symbol of the rise of domestic brands, but also a microcosm of the changes in the domestic medical equipment market pattern. The advantages of domestic brands in technology, cost, and policy support make them stand out in market competition. In the future, with the further development of technology and the further opening up of the market, domestic brands are expected to achieve breakthroughs in more fields, promoting the localization process of the domestic medical equipment market.

Source: http://qixieke.com/Font/index/detailPage.html?id=3372-19

By editor
Share: 

your submission has already been received.

OK

Subscribe

Please enter a valid Email address!

Submit

The most relevant industry news & insight will be sent to you every two weeks.